Christopher Hoover, MD
Urology · Gallup, NMNPI 1982925673
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 69.6% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $656, more than ten times the $51 reported in 2022. That places this record below the midpoint for urology clinicians in NM, where the typical reported total is $1,519.
Across 12 payments — averaging $84.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$706
- Vertos Medical, Inc.$276
- Bayer$12
- Urogen Pharma, Inc.$12
- Itamar Medical Inc$8
What the payments were for
- Travel & lodging$40540%
- Food & beverage$59859%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 7 | $706 |
| Vertos Medical, Inc. | 2 | $276 |
| Bayer | 1 | $12 |
| Urogen Pharma, Inc. | 1 | $12 |
| Itamar Medical Inc | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTAVIVA$358
- mild Device Kit$276
How this compares
$1,015 in reported general payments places this provider in the 40th percentile of 46 urology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 118 | $55,212 |
| Estradiol | 66 | $4,532 |
| Methenamine Hippurate | 66 | $4,357 |
| Potassium Citrate ErPotassium Citrate | 27 | $3,919 |
| Tamsulosin Hcl | 65 | $1,220 |
| Finasteride | 61 | $942 |
| Terazosin Hcl | 12 | $238 |
| Cephalexin | 31 | $96 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 37 | $81 |
| Levofloxacin | 20 | $68 |
| Fluconazole | 12 | $37 |
| Ciprofloxacin Hcl | 20 | $37 |
Paid to pharmacies, not to this prescriber.
Other urology in Gallup
- John WrightGallup$213
- Benjamin MontgomeryLovington$166K
- Wayne KuangAlbuquerque$128K
- Jordan ForemanAlbuquerque$60K
- Emma BendanaLas Cruces$18K
- Andrew GrollmanAlbuquerque$16K
- Aaron GeswaldoAlbuquerque$11K
- Jonathan NelsonAlbuquerque$6K
- Robert KolosseusLas Cruces$5K
- Stefan GutowAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.